Table 2.
Dataset | Onset stage | N | % | 28-day survival time
|
60-day survival time
|
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | ||||||
Derivation | Early | 377 | 72.50 | Ref | Ref | ||||||
Late | 143 | 27.50 | 2.24 | 1.48 | 3.39 | 1.24 × 10−4 | 1.70 | 1.16 | 2.48 | 6.62 × 10−3 | |
| |||||||||||
Validation | Early | 226 | 63.48 | Ref | |||||||
Late | 130 | 36.52 | 2.16 | 1.33 | 3.51 | 1.95 × 10−3 | 1.78 | 1.15 | 2.75 | 9.80 × 10−3 | |
| |||||||||||
Combined | Early | 603 | 68.84 | Ref | |||||||
Late | 273 | 31.16 | 2.00 | 1.47 | 2.72 | 1.10 × 10−5 | 1.59 | 1.20 | 2.10 | 1.22 × 10−3 |
HR hazard ratio, 95% CI 95% confidence interval, HR 95% CI and P values were adjusted for variables collected within 24 h of ICU admission (APACHE III score, septic shock, pneumonia, multiple fractures, transfusion within 7 days prior to admission, vasopressors prior to admission, intubation, ventilation, and highest potassium level), variables collected at time of ARDS onset (PaO2/FiO2, platelet count, and creatinine level), and ICU 28-day ventilation-free days in the Cox proportional hazards model; ARDS onset within 48 h after admission was defined as early-onset, and otherwise as late-onset stage